Počet záznamov: 1
donory oxidu dusnatého
SYS d020030 LBL 00000cz--a2200000n--4500 005 20250606213122.4 008 980610|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a D27.505.519.656 065 $a D27.505.954.411.590 066 $a 01 $c 03 150 $a donory oxidu dusnatého $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a donor kysličníka dusnatého $2 slo 550 $7 sllk_us_auth*d005996 $Y Nitroglycerin $w b $a nitroglycerín 550 $7 sllk_us_auth*d009569 $Y Nitric Oxide $w b $a oxid dusnatý 550 $7 sllk_us_auth*d009569 $Y Nitric Oxide $w p $a oxid dusnatý 665 $a 1999 $2 eng 665 $a Nitric Oxide (1990-1998) $2 eng 680 9-
$i A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) $2 eng 750 -2
$a Nitric Oxide Donors $2 eng 980 $x M
Počet záznamov: 1